Royal Bank of Canada Sells 34,080 Shares of Constellium SE $CSTM

Royal Bank of Canada cut its stake in Constellium SE (NYSE:CSTM) by 67.1% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 16,725 shares of the industrial products company’s stock after selling 34,080 shares during the period. Royal Bank of Canada’s holdings in Constellium were worth $411,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Millennium Management LLC raised its position in shares of Constellium by 35.4% in the 3rd quarter. Millennium Management LLC now owns 6,935,766 shares of the industrial products company’s stock worth $103,204,000 after acquiring an additional 1,813,400 shares in the last quarter. Encompass Capital Advisors LLC boosted its position in shares of Constellium by 9.2% during the fourth quarter. Encompass Capital Advisors LLC now owns 4,657,915 shares of the industrial products company’s stock valued at $87,802,000 after purchasing an additional 393,640 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Constellium by 22.9% during the fourth quarter. Vanguard Group Inc. now owns 4,054,982 shares of the industrial products company’s stock valued at $76,436,000 after purchasing an additional 755,918 shares in the last quarter. Morgan Stanley grew its stake in Constellium by 48.4% in the fourth quarter. Morgan Stanley now owns 3,728,118 shares of the industrial products company’s stock worth $70,275,000 after purchasing an additional 1,216,516 shares during the period. Finally, Arrowstreet Capital Limited Partnership grew its stake in Constellium by 620.9% in the first quarter. Arrowstreet Capital Limited Partnership now owns 3,228,027 shares of the industrial products company’s stock worth $79,345,000 after purchasing an additional 2,780,260 shares during the period. 92.59% of the stock is owned by institutional investors.

Constellium Trading Up 0.6%

NYSE CSTM opened at $27.23 on Thursday. Constellium SE has a 12 month low of $13.58 and a 12 month high of $36.99. The company has a current ratio of 1.43, a quick ratio of 0.61 and a debt-to-equity ratio of 1.50. The stock’s fifty day moving average price is $29.56 and its 200-day moving average price is $29.27. The stock has a market cap of $3.69 billion, a P/E ratio of 7.02 and a beta of 1.57.

Constellium (NYSE:CSTM) last announced its quarterly earnings results on Wednesday, July 29th. The industrial products company reported $1.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.86 by $0.18. Constellium had a net margin of 5.69% and a return on equity of 51.66%. The company had revenue of $2.75 billion for the quarter, compared to analysts’ expectations of $2.73 billion. During the same quarter in the previous year, the business posted $0.25 EPS. Constellium’s revenue was up 30.7% compared to the same quarter last year. As a group, equities analysts forecast that Constellium SE will post 3.7 EPS for the current fiscal year.

Insider Transactions at Constellium

In other news, Director Jean-Christophe Deslarzes purchased 1,490 shares of the business’s stock in a transaction dated Monday, August 3rd. The shares were purchased at an average price of $27.24 per share, for a total transaction of $40,587.60. Following the completion of the acquisition, the director directly owned 43,515 shares in the company, valued at $1,185,348.60. This represents a 3.55% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director John Ormerod sold 8,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $35.01, for a total transaction of $280,080.00. Following the sale, the director directly owned 24,873 shares of the company’s stock, valued at $870,803.73. This trade represents a 24.34% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.20% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the company. UBS Group lowered their price objective on Constellium from $38.00 to $35.00 and set a “buy” rating for the company in a research report on Wednesday, July 8th. Zacks Research downgraded shares of Constellium from a “strong-buy” rating to a “hold” rating in a research report on Monday, June 29th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $34.00 price target (up from $30.00) on shares of Constellium in a research note on Thursday, April 30th. Deutsche Bank Aktiengesellschaft set a $39.00 price target on shares of Constellium in a research report on Thursday, July 30th. Finally, Wells Fargo & Company boosted their price objective on shares of Constellium from $37.00 to $39.00 and gave the stock an “overweight” rating in a research note on Thursday, July 30th. Four equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, Constellium has an average rating of “Moderate Buy” and an average target price of $35.80.

Constellium Profile

Constellium SE is a global leader in the design and manufacture of high-performance aluminum products and solutions. The company serves key markets including aerospace, automotive, and packaging, offering advanced rolled and extruded aluminum sheet, plate and structural components. Its product portfolio encompasses precision-engineered parts for commercial and military aircraft, automotive body structures and closures, beverage and specialty packaging, as well as industrial and structural applications.

Established in 2011 through the consolidation of Rio Tinto Alcan’s rolled-products and engineered-products businesses, Constellium has built a reputation for innovation in lightweighting and sustainability.